Grip strength as a predictor of disease severity in hospitalized COVID-19 patients

被引:36
|
作者
Kara, Ozgur [1 ]
Kara, Murat [2 ]
Akin, Mustafa Emre [3 ]
Ozcakar, Levent [2 ]
机构
[1] Yildirim Beyazit Univ, Yenimahalle Training & Res Hosp, Geriatr Unit, Ankara, Turkey
[2] Hacettepe Univ, Dept Phys & Rehabil Med, Med Sch, Ankara, Turkey
[3] Yildirim Beyazit Univ, Yenimahalle Training & Res Hosp, Radiol Unit, Ankara, Turkey
来源
HEART & LUNG | 2021年 / 50卷 / 06期
关键词
Coronavirus; Hand; Muscle; Sarcopenia; Frailty; CORONAVIRUS DISEASE; CT;
D O I
10.1016/j.hrtlng.2021.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Grip strength is one of the main components for the physical functioning in sarcopenia and physical frailty. Objectives: To explore the role of grip strength measurement at admission for predicting disease severity in COVID-19. Methods: Demographic data, smoking status, comorbidities, COVID-19 related symptoms, grip strength, laboratory and computed tomography (CT) findings at admission were all noted. Using a Smedley hand dynamometer, the maximum grip strength value (kg) after three measurements on the dominant side was recorded. Low grip strength was defined as two standard deviations below the gender-specific peak mean value of the healthy young adults (<32 kg for males, <19 kg for females). Patients were categorized into three groups according to clinical and CT findings. Severe illness group had pneumonia with a respiratory rate >30/min, oxygen saturation similar to 90%, or extensive lung involvement in CT. Moderate illness group had pneumonia with CT score similar to 11. Mild illness group had normal CT findings. Results: The study population included 312 patients (140 F, 172 M). The distribution ofmild, moderate and severe disease groups were 36.9%, 51.0% and 12.2%, respectively. Cough, fever, dyspnea, hypertension, obesity, cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) were most frequent, and C-reactive protein (CRP), ferritin, D-dimer, and neutrophil levels were highest in the severe group (all p<.05). Absolute grip strength values were lowest and the frequency of having low grip strength were highest in the severe group (both p<.01). Since we found that the significant differences were stemming from the severe group, we combined themild andmoderate group as non-severe, and compared severe vs. non-severe groups with binary logistic regression analyses. When age, gender, body mass index, smoking status, presence of comorbidities and low grip strength, and abnormal laboratory findings were taken into analyses; age (odds ratio [OR]: 1.054 [95% confidence interval (CI): 1.020-1.089]), obesity (OR: 2.822 [95% CI: 1.143-6.966]), COPD (OR: 5.699 [95 %CI: 1.23126.383]), CRP level (OR: 1.023 [95% CI: 1.010-1.036]) and low grip strength (OR: 3.047 [95% CI: 1.146-8.103]) were observed to be independent predictors for severe COVID-19 disease (all p<.05). Conclusions: In addition to the well-known independent risk factors (i.e. age, obesity, COPD, and CRP level), low grip strength independently increased (about three times) the severity of COVID-19. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:743 / 747
页数:5
相关论文
共 50 条
  • [1] Comment on "Grip strength as a predictor of disease severity in hospitalized COVID-19 patients"
    Sajid, Samar
    [J]. HEART & LUNG, 2023, 57 : 296 - 296
  • [2] Authors response to: Comment on "Grip strength as a predictor of disease severity in hospitalized COVID-19 patients"
    Kara, Ozgur
    Kara, Murat
    Akin, Mustafa Emre
    Ozcakar, Levent
    [J]. HEART & LUNG, 2023, 57 : 297 - 297
  • [3] Ferritin level: A predictor of severity and mortality in hospitalized COVID-19 patients
    Alroomi, Moudhi
    Rajan, Rajesh
    Omar, Abdulaziz A.
    Alsaber, Ahmad
    Pan, Jiazhu
    Fatemi, Mina
    Zhanna, Kobalava D.
    Aboelhassan, Wael
    Almutairi, Farah
    Alotaibi, Naser
    Saleh, Mohammad A.
    AlNasrallah, Noor
    Al-Bader, Bader
    Malhas, Haya
    Ramadhan, Maryam
    Abdullah, Mohammed
    Abdelnaby, Hassan
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1648 - 1655
  • [4] Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19
    Tuzun, Sansin
    Keles, Aslinur
    Okutan, Dilara
    Yildiran, Tugbay
    Palamar, Deniz
    [J]. EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2021, 57 (04) : 653 - 662
  • [5] COVID-19 Severity Index ( SI): is it a sensitive predictor score for disease outcome in hospitalized patients?
    Gashynova, K.
    Rudakova, V.
    Rodionova, V.
    But, N.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] The AIFELL Score as a Predictor of Coronavirus Disease 2019 (COVID-19) Severity and Progression in Hospitalized Patients
    Levenfus, Ian
    Ullmann, Enrico
    Petrowski, Katja
    Rose, Jutta
    Huber, Lars C.
    Stuessi-Helbling, Melina
    Schuurmans, Mace M.
    [J]. DIAGNOSTICS, 2022, 12 (03)
  • [7] IMMATURE PLATELETS AND DISEASE SEVERITY IN HOSPITALIZED PATIENTS WITH COVID-19
    Urrechaga, Eloisa
    Fernandez, Monica
    Merino, Monica
    Mugertza, Garazi
    Ponga, Cristina
    Naharro, Imanol
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 120 - 121
  • [8] COVID-19 Severity in Hospitalized Pediatric Patients with Atopic Disease
    Timberlake, Dylan
    Scherzer, Rebecca
    Prince, Benjamin
    Grayson, Mitchell
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB79 - AB79
  • [9] Severity of COVID-19 in hospitalized patients with and without atopic disease
    Timberlake, Dylan T.
    Narayanan, Deepika
    Ogbogu, Princess U.
    Raveendran, Rekha
    Porter, Kyle
    Scherzer, Rebecca
    Prince, Benjamin
    Grayson, Mitchell H.
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (02):
  • [10] Neopterin Predicts Disease Severity in Hospitalized Patients With COVID-19
    Bellmann-Weiler, Rosa
    Lanser, Lukas
    Burkert, Francesco
    Seiwald, Stefanie
    Fritsche, Gernot
    Wildner, Sophie
    Schroll, Andrea
    Koppelstatter, Sabine
    Kurz, Katharina
    Griesmacher, Andrea
    Weiss, Gunter
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (01):